amobarbital has been researched along with Basal Ganglia Diseases in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BRUNE, GG | 1 |
| KOBAYASHI, T | 1 |
| BULL, C | 1 |
| TOURLENTES, TT | 1 |
| HIMWICH, HE | 1 |
| DA PIAN, R | 1 |
| BRICOLO, A | 1 |
| DALLE ORE, G | 1 |
| PERBELLINI, D | 1 |
2 other studies available for amobarbital and Basal Ganglia Diseases
| Article | Year |
|---|---|
Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.
Topics: Amobarbital; Antipsychotic Agents; Basal Ganglia Diseases; Combined Modality Therapy; Disease; Extra | 1962 |
[Intracarotid sodium amytal. Clinical and electroencephalographic study on the modifications of extrapyramidal symptoms].
Topics: Amobarbital; Basal Ganglia Diseases; Disease; Electroencephalography; Extrapyramidal Tracts; Humans | 1961 |